Researcher

Antonio Bertoletti trained as a specialist in infectious diseases at the Scripps Research Institute, US, and the University of Parma, Italy, where he was the first to characterize hepatitis B virus (HBV)-specific CD8+ T cells. Subsequently, he moved to University College of London in 1997 where he pioneered the use of HLA-tetramers to characterize the role of HBV-specific T cells in viral control and disease pathogenesis. In 2006, he became the Director of the Infection and Immunity Program at A*STAR’s Singapore Institute for Clinical Sciences before joining Duke-NUS Medical School in 2013.